Searchable abstracts of presentations at key conferences in endocrinology

ea0045p16 | Diabetes | BSPED2016

An Audit of the Paediatric Diabetes Out Of Hours Advice Service using the Best Practice Tariff Criteria

Starr Emma , Quintela Ella , Denvir Louise , Sachdev Pooja

Background/Introduction: The Best Practice Tariff was introduced in 2012 in England and Wales to provide adequate funding and ensure quality care for all children with Diabetes. The tariff criteria states that units must provide “24 hour access to advice and support” including “24 hour expert advice to other healthcare professionals”. The aims of this audit were to: evaluate the Nottingham Children’s Hospital out of hours paediatric diabetes service, d...

ea0045p21 | Diabetes | BSPED2016

Efficacy and uptake of an education clinic integrated into an MDT clinic for children with type 1 diabetes

Quintela Ella , Drew Josephine , Denvir Louise , Randell Tabitha , Sachdev Pooja

Introduction: The Best Practice Tariff states that units must provide a structured education programme which should be ‘tailored to the child’s needs, both at the time of initial diagnosis and ongoing updates’. Traditionally, there has been poor uptake of our education sessions with attendance rates of 20% (range 0–30). Therefore, an integrated education clinic was introduced which combined education within a multidisciplinary (MDT) clinic session for ongoi...

ea0045p41 | Diabetes | BSPED2016

High HBA1c pathway for children and young people with poor glycaemic control: process and outcomes

Fradley Wayne , Sachdev Pooja , Randell Tabitha , Denvir Louise

Background: Children and Young People (C&YP) with poorly controlled diabetes are at increased risk of diabetic ketoacidosis (DKA) and long-term sequelae. There is no clear evidence about how best to manage them. NPDA data highlights that UK numbers are in decline, but still constitutes 21.3% of C&YP with diabetes. The high HbA1c pathway at Nottingham Children’s Hospital (NCH) aims to systematically identify and support C&YP with HbA1c >80 mmol/mol. It prov...

ea0095oc9.3 | Oral Communications 9 | BSPED2023

A National Survey on the care and management of Children and Young people with Type 2 Diabetes

Uday Suma , Anilkumar Anjitha , Clark Heather , Walker Anthony , Sachdev Pooja

Background: The National Paediatric Diabetes audit (NPDA) reports increasing number of children and young people with type 2 diabetes (CYP2D). CYP2D are less likely to receive all recommended health checks compared to those with type 1 diabetes (33% vs 59% respectively) and do not receive treatment for complications even when they are identified (T2D spotlight audit 2019/20). We assessed variation in care across different units against the national T2D guideli...

ea0095oc9.5 | Oral Communications 9 | BSPED2023

Impact of using hybrid closed loop system in a tertiary children’s hospital: a single centre experience

B. Kamaleldeen Eman , L Randell Tabitha , Sachdev Pooja

Background: Hybrid closed loop (HCL) insulin systems are associated with better glycaemic control and reduced hypoglycaemia risk. They represent the most advanced form of insulin delivery for people with type 1 diabetes mellitus (T1DM).Aim: The study aimed to evaluate effectiveness of 3 HCL systems in children and young people (CYP) with T1DM at Nottingham Children’s Hospital.Methods:<...

ea0095p5 | Adrenal 1 | BSPED2023

Retrospective review of patients with 21-hydroxylase deficiency (21OHD) Congenital adrenal hyperplasia (CAH) in a tertiary children’s hospital

Riches Katherine , Abey Rose , Denvir Louise , Law James , Sachdev Pooja

Background: The most common form (90%) of CAH is 21-hydroxylase deficiency (21OHD). Management is with hydrocortisone ±fludrocortisone replacement while minimising side effects of androgen excess. Our aim was to review our CAH cohort and describe their characteristics, treatment regimens and growth.Methods: Retrospective data on height, weight, BMI, bone age and biochemical profiles was collected on 26 patients with...

ea0095p41 | Gonadal, DSD and Reproduction 1 | BSPED2023

A retrospective analysis of clinical characteristics, testosterone therapy, and comorbidity screening for klinefelter syndrome: Insights from a UK tertiary centre over the last two decades

Jeevarathnam Dhivyalakshmi , Chandwani Manju , Dixit Abhijit , Sachdev Pooja

The European Academy of Andrology (EAA) recently published consensus guidelines aiming to standardize the care provided to patients with Klinefelter syndrome (KS) across different stages of development. In this retrospective cross-sectional study, we reviewed the clinical care provided to 76 KS patients at Nottingham University Hospitals between 2000 and 2020.Methods: Data regarding age at presentation (n=30 paediatric, adult 46...

ea0078OC7.2 | Oral Communications 7 | BSPED2021

Multi-centre service evaluation of presentation of newly diagnosed type 1 diabetes in children in the U.K. furing the COVID-19 pandemic

McLean Ross , Mitchell Rod , Sachdev Pooja , Conway Nicky , Liu Jo-Fen

Background: The COVID-19 pandemic led to major changes in the pattern of presentation to Emergency Departments. This prompted concern within Paediatrics that this altered behaviour could lead to delays in the diagnosis of life-threatening conditions such as type 1 diabetes. A multicentre study was conducted to determine the incidence, referral patterns and severity of disease at presentation of this condition. Methods: This was a U.K.-based multi-centre ...

ea0051p050 | Pituitary and growth | BSPED2017

Siblings with 3-M Syndrome show good response to Growth Hormone (GH) therapy over a 4 year follow-up growth data

Mohamed Zainaba , Sachdev Pooja , Benson Joanna , Hastings Richard , Randell Tabitha , Denvir Louise

Introduction: 3M syndrome is a rare autosomal recessive condition that causes short stature, unusual facial features and skeletal abnormalities with normal intelligence. Mutations in CUL7, OBSL1 and CCDC8 genes have been identified as pathogenic. GH treatment outcomes for 3M syndrome appear controversial. Use of human recombinant GH for the treatment of short stature has been trialled in previous studies with some suggesting dysregulation in GH/IGF1 axis while others report no...

ea0051p069 | Diabetes | BSPED2017

A review of patients not carbohydrate counting in a Paediatric Diabetes Clinic

Briggs Rebecca , Denvir Louise , Randell Tabitha , Keeton Rachel , Sachdev Pooja , Calvert Jennifer

Background: NICE recommendation is to use multiple daily insulin injections and to offer level 3 carbohydrate-counting education at diagnosis of Type 1 diabetes (T1DM), and at least at annual intervals thereafter. Best Practice Tariff states that every young person with diabetes should be offered at least one additional appointment per year with a paediatric dietitian with training in diabetes. Our aim was to identify details of all the patients in the current cohort who were ...